Filing Flows › Assembly Biosciences (ASMB) › Q2 2026 › vs Q1 2026
Assembly Biosciences (ASMB) Q2 2026 vs Q1 2026 (quarter over quarter)
Assembly Biosciences's revenue rose $5.2M (+63%) from $8.2M in Q1 2026 to $13.4M in Q2 2026.
Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $13.4M | $8.2M | $5.2M | +63% |
| Other income, net | $2.5M | $2.3M | $196K | +9% |
| Net loss | $3.9M | $9.1M | −$5.2M | -58% |
| Costs & expenses | $19.7M | $19.6M | $135K | +0.7% |
| Operating costs | $19.7M | $19.6M | $135K | +0.7% |
| Research & development | $14.9M | $14.9M | $17K | +0.1% |
| General & admin | $4.8M | $4.7M | $118K | +3% |
| Operating cash sources | $17.9M | $23.2M | −$5.3M | -23% |
| Depreciation & amortization | $20K | $26K | −$6K | -23% |
| Share-based compensation | $2.4M | $1.1M | $1.3M | +116% |
| Cash used in operations | $15.5M | $22.1M | −$6.6M | -30% |
| Net loss absorbed | $3.9M | $9.1M | −$5.2M | -58% |
| Working capital & other | $14.1M | $14.2M | −$93K | -0.7% |
Questions
How much did Assembly Biosciences's revenue grow quarter over quarter in Q2 2026?
Assembly Biosciences's revenue rose $5.2M (+63%) from $8.2M in Q1 2026 to $13.4M in Q2 2026.